Hong Kong stock abnormal | Uni-Bio Science (00512.HK) rose more than 4% after the performance announcement. First half-year revenue hits a record high. Yee Kam Tai is expected to lead the company to achieve high performance growth.

According to the Wise News Financial APP, Uni-medical Pharma (00512.HK) rose by more than 4% after its performance announcement. As of the time of writing, it had risen by 4.26% to 9.3 Hong Kong dollars, with a trading volume of 339 million Hong Kong dollars.